A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.
Now, one scientist is using artificial intelligence to find new uses for existing drugs in an effort to fight cancer. Channel ...
8d
News Medical on MSNAI could play a key role in improving prostate cancer treatment outcomesA study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...
This helps doctors more accurately see the true size and boundaries of the cancer. To evaluate the accuracy of the AI software, the team enrolled 204 men with localized prostate cancer who ...
8d
News-Medical.Net on MSN$1 million CPRIT grant focuses on AI to improve prostate cancer outcomesErzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...
Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of ...
A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and radiation therapies.
AI is rapidly gaining traction in medicine, offering benefits like reducing administrative burdens and supporting diagnoses, ...
First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...
the company's artificial intelligence (AI)-supported system for prostate cancer detection and diagnosis. Another AI-supported system showed promise for more accurate determination of tumor size in ...
"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...
In addition to its scientific sessions, PathAI will host H&E by the Sea, an AI-powered pathology networking event on March 25 th at 6:00 p.m. ET at the Nautilus Pier 4. The event will bring together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results